Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Identification
HMDB Protein ID HMDBP14510
Secondary Accession Numbers None
Name Beta-arrestin-2
Synonyms
  1. Arrestin beta-2
Gene Name ARRB2
Protein Type Unknown
Biological Properties
General Function Not Available
Specific Function Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in IL8-mediated granule release in neutrophils (By similarity). Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN. Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in the internalization of the atypical chemokine receptor ACKR3 (By similarity). Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis. During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of proinflammatory cytokine release and inhibition of inflammation.
Pathways
  • Chemical carcinogenesis - receptor activation
  • Chemokine signaling pathway
  • Dopaminergic synapse
  • Endocytosis
  • GnRH secretion
  • Hedgehog signaling pathway
  • MAPK signaling pathway
  • Morphine addiction
  • Olfactory transduction
  • Parathyroid hormone synthesis, secretion and action
  • Relaxin signaling pathway
Reactions Not Available
GO Classification
Biological Process
transcription from RNA polymerase II promoter
negative regulation of release of cytochrome c from mitochondria
negative regulation of protein ubiquitination
negative regulation of neuron apoptotic process
cell chemotaxis
protein transport
G-protein coupled receptor signaling pathway
negative regulation of interleukin-1 beta production
receptor internalization
negative regulation of tumor necrosis factor production
positive regulation of DNA biosynthetic process
positive regulation of collagen biosynthetic process
positive regulation of protein phosphorylation
regulation of G-protein coupled receptor protein signaling pathway
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
positive regulation of ERK1 and ERK2 cascade
G-protein coupled receptor internalization
negative regulation of GTPase activity
negative regulation of protein phosphorylation
positive regulation of peptidyl-tyrosine phosphorylation
adult walking behavior
negative regulation of NF-kappaB transcription factor activity
positive regulation of protein kinase B signaling cascade
brain development
positive regulation of calcium ion transport
desensitization of G protein-coupled receptor signaling pathway by arrestin
follicle-stimulating hormone signaling pathway
negative regulation of natural killer cell mediated cytotoxicity
negative regulation of toll-like receptor signaling pathway
positive regulation of cardiac muscle cell differentiation
negative regulation of smooth muscle cell apoptotic process
positive regulation of epithelial cell apoptotic process
positive regulation of synaptic transmission, dopaminergic
positive regulation of receptor internalization
negative regulation of interleukin-6 production
regulation of protein phosphorylation
transforming growth factor beta receptor signaling pathway
detection of temperature stimulus involved in sensory perception of pain
positive regulation of gene expression
endocytosis
proteasomal ubiquitin-dependent protein catabolic process
positive regulation of peptidyl-serine phosphorylation
negative regulation of interleukin-12 production
protein ubiquitination
Cellular Component
cytosol
cytoplasm
endocytic vesicle
postsynaptic membrane
nucleus
nucleoplasm
coated pit
basolateral plasma membrane
dendritic spine
cytoplasmic vesicle
postsynaptic density
endosome
Molecular Function
protein-containing complex binding
G protein-coupled receptor binding
ubiquitin protein ligase binding
receptor binding
alpha-1A adrenergic receptor binding
alpha-1B adrenergic receptor binding
14-3-3 protein binding
angiotensin receptor binding
D1 dopamine receptor binding
follicle-stimulating hormone receptor binding
mitogen-activated protein kinase binding
platelet activating factor receptor binding
type 2A serotonin receptor binding
protein domain specific binding
enzyme binding
arrestin family protein binding
protein kinase B binding
identical protein binding
type 1 angiotensin receptor binding
Cellular Location Not Available
Gene Properties
Chromosome Location Not Available
Locus Not Available
SNPs Not Available
Gene Sequence Not Available
Protein Properties
Number of Residues 410
Molecular Weight 46339.635
Theoretical pI 7.667
Pfam Domain Function
Signals Not Available
Transmembrane Regions Not Available
Protein Sequence Not Available
GenBank ID Protein Not Available
UniProtKB/Swiss-Prot ID P29067
UniProtKB/Swiss-Prot Entry Name ARRB2_RAT
PDB IDs
GenBank Gene ID Not Available
GeneCard ID Not Available
GenAtlas ID Not Available
HGNC ID Not Available
References
General References
  1. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [PubMed:15489334 ]
  2. Bolger GB, McCahill A, Huston E, Cheung YF, McSorley T, Baillie GS, Houslay MD: The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestins. J Biol Chem. 2003 Dec 5;278(49):49230-8. Epub 2003 Sep 18. [PubMed:14500724 ]
  3. Wallace DA, Johnston LA, Huston E, MacMaster D, Houslay TM, Cheung YF, Campbell L, Millen JE, Smith RA, Gall I, Knowles RG, Sullivan M, Houslay MD: Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene. Mol Pharmacol. 2005 Jun;67(6):1920-34. Epub 2005 Feb 28. [PubMed:15738310 ]
  4. Miller WE, Maudsley S, Ahn S, Khan KD, Luttrell LM, Lefkowitz RJ: beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis. J Biol Chem. 2000 Apr 14;275(15):11312-9. [PubMed:10753943 ]
  5. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ: beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8603-7. Epub 2004 Jun 1. [PubMed:15173580 ]
  6. Lin FT, Daaka Y, Lefkowitz RJ: beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J Biol Chem. 1998 Nov 27;273(48):31640-3. [PubMed:9822622 ]
  7. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Girnita A, Lefkowitz RJ, Larsson O: {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J Biol Chem. 2005 Jul 1;280(26):24412-9. Epub 2005 May 3. [PubMed:15878855 ]
  8. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ: Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science. 2000 Nov 24;290(5496):1574-7. [PubMed:11090355 ]
  9. Wu JH, Peppel K, Nelson CD, Lin FT, Kohout TA, Miller WE, Exum ST, Freedman NJ: The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor. J Biol Chem. 2003 Nov 7;278(45):44238-45. Epub 2003 Aug 27. [PubMed:12944399 ]
  10. Kraft K, Olbrich H, Majoul I, Mack M, Proudfoot A, Oppermann M: Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization. J Biol Chem. 2001 Sep 14;276(37):34408-18. Epub 2001 Jul 11. [PubMed:11448957 ]
  11. Guo C, Whitmarsh AJ: The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus. J Biol Chem. 2008 Jun 6;283(23):15903-11. doi: 10.1074/jbc.M710006200. Epub 2008 Apr 11. [PubMed:18408005 ]
  12. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, Lefkowitz RJ: Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem. 1992 Sep 5;267(25):17882-90. [PubMed:1517224 ]
  13. Puca L, Chastagner P, Meas-Yedid V, Israel A, Brou C: Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate Notch degradation in mammals. J Cell Sci. 2013 Oct 1;126(Pt 19):4457-68. doi: 10.1242/jcs.130500. Epub 2013 Jul 25. [PubMed:23886940 ]
  14. Craft CM, Whitmore DH, Wiechmann AF: Cone arrestin identified by targeting expression of a functional family. J Biol Chem. 1994 Feb 11;269(6):4613-9. [PubMed:8308033 ]
  15. Komori N, Cain SD, Roch JM, Miller KE, Matsumoto H: Differential expression of alternative splice variants of beta-arrestin-1 and -2 in rat central nervous system and peripheral tissues. Eur J Neurosci. 1998 Aug;10(8):2607-16. [PubMed:9767391 ]
  16. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, Barak LS: The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3712-7. doi: 10.1073/pnas.96.7.3712. [PubMed:10097102 ]
  17. Bremnes T, Paasche JD, Mehlum A, Sandberg C, Bremnes B, Attramadal H: Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem. 2000 Jun 9;275(23):17596-604. doi: 10.1074/jbc.M000142200. [PubMed:10747877 ]
  18. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG: The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits. J Biol Chem. 2000 Jul 28;275(30):23120-6. doi: 10.1074/jbc.M002581200. [PubMed:10770944 ]
  19. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ: Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2449-54. doi: 10.1073/pnas.041604898. Epub 2001 Feb 20. [PubMed:11226259 ]
  20. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ: Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 2001 Nov 9;294(5545):1307-13. doi: 10.1126/science.1063866. Epub 2001 Oct 4. [PubMed:11588219 ]
  21. Lin FT, Chen W, Shenoy S, Cong M, Exum ST, Lefkowitz RJ: Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors. Biochemistry. 2002 Aug 27;41(34):10692-9. doi: 10.1021/bi025705n. [PubMed:12186555 ]
  22. Laporte SA, Miller WE, Kim KM, Caron MG: beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin. J Biol Chem. 2002 Mar 15;277(11):9247-54. doi: 10.1074/jbc.M108490200. Epub 2002 Jan 2. [PubMed:11777907 ]
  23. Braun L, Christophe T, Boulay F: Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway. J Biol Chem. 2003 Feb 7;278(6):4277-85. doi: 10.1074/jbc.M210120200. Epub 2002 Dec 2. [PubMed:12464600 ]
  24. Chen W, Ren XR, Nelson CD, Barak LS, Chen JK, Beachy PA, de Sauvage F, Lefkowitz RJ: Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science. 2004 Dec 24;306(5705):2257-60. doi: 10.1126/science.1104135. [PubMed:15618519 ]
  25. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG: An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 2005 Jul 29;122(2):261-73. doi: 10.1016/j.cell.2005.05.012. [PubMed:16051150 ]
  26. Shenoy SK, Lefkowitz RJ: Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem. 2005 Apr 15;280(15):15315-24. doi: 10.1074/jbc.M412418200. Epub 2005 Feb 7. [PubMed:15699045 ]
  27. Shenoy SK, Barak LS, Xiao K, Ahn S, Berthouze M, Shukla AK, Luttrell LM, Lefkowitz RJ: Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J Biol Chem. 2007 Oct 5;282(40):29549-62. doi: 10.1074/jbc.M700852200. Epub 2007 Jul 31. [PubMed:17666399 ]
  28. Lee MH, El-Shewy HM, Luttrell DK, Luttrell LM: Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription. J Biol Chem. 2008 Jan 25;283(4):2088-97. doi: 10.1074/jbc.M706892200. Epub 2007 Nov 15. [PubMed:18006496 ]
  29. Mosser VA, Jones KT, Hoffman KM, McCarty NA, Jackson DA: Differential role of beta-arrestin ubiquitination in agonist-promoted down-regulation of M1 vs M2 muscarinic acetylcholine receptors. J Mol Signal. 2008 Dec 3;3:20. doi: 10.1186/1750-2187-3-20. [PubMed:19055777 ]